lanthanum carbonate 750 MG Oral Powder [Fosrenol]
- RxCUI
- 1551886
- RxNorm name
- lanthanum carbonate 750 MG Oral Powder [Fosrenol]
- Display name
- lanthanum carbonate 750 MG Oral Powder [Fosrenol]
- Full name
- lanthanum carbonate 750 MG Oral Powder [Fosrenol]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:27
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fosrenol | LANTHANUM CARBONATE | Takeda Pharmaceuticals America, Inc. | f10776b2-2c25-4343-aabe-68f302e5cb54 | 2024-12-31 | Warnings, Adverse reactions | 1551886 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f10776b2-2c25-4343-aabe-68f302e5cb54 | Fosrenol 750 MG Oral Powder [PSN] · lanthanum carbonate 750 MG Oral Powder [Fosrenol] [SBD] · Fosrenol 750 MG Oral Powder [SY] | 3 | 58 | These highlights do not include all the information needed to use FOSRENOL safely and effectively. See full prescribing information for FOSRENOL. FOSRENOL ® (lanthanum carbonate) chewable tablets, for oral use FOSRENOL ® (lanthanum carbonate) oral powder, for oral use Initial U.S. Approval: 2004 | 20241231 |